We are live on
!
Find out more
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
56 hedge funds and large institutions have $160M invested in CTI BioPharma Corp. (DE) Common Stock in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
20% more capital invested
Capital invested by funds: $133M → $160M (+$26.5M)
12% more funds holding
Funds holding: 50 → 56 (+6)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
33% less call options, than puts
Call options by funds: $287K | Put options by funds: $431K
Holders
56
Holders Change
+6
Holders Change %
+12%
% of All Funds
0.98%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
13
Reduced
15
Closed
7
Calls
$287K
Puts
$431K
Net Calls
-$144K
Net Calls Change
-$647K
Top Buyers
Top Sellers
| 1 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$3.58M |
| 2 |
Renaissance Technologies
New York
|
-$1.77M |
| 3 |
Morgan Stanley
New York
|
-$1.39M |
| 4 |
ACM
Altium Capital Management
New York
|
-$996K |
| 5 |
Two Sigma Investments
New York
|
-$552K |
